Tamer Khayal
Vermögen: 1 Mio $ am 31.05.2026
Vermögen: 1 Mio $ am 31.05.2026
Tamer I.
Khayal is Chief Medical Officer at TransMedics, Inc. since 2013 and Senior Vice President-International at TransMedics Group, Inc. starting in 2026.
Formerly, Dr. Khayal was Director-Clinical Affairs at Zentiva Group.
Education includes a doctorate from KasrAlAiny School of Medicine conferred in 1993.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 15’038 ( 0.04% ) | 1 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| TRANSMEDICS GROUP, INC. | Corporate Officer/Principal | 01.01.2018 |
TransMedics, Inc.
TransMedics, Inc. Medical SpecialtiesHealth Technology Manufactures and develops medical devices | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2001 |
| Unternehmen | Position | Ende |
|---|---|---|
Zentiva Group as
Zentiva Group as Pharmaceuticals: MajorHealth Technology Manufactures, develops and markets generics & pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Zentiva Group as
Zentiva Group as Pharmaceuticals: MajorHealth Technology Manufactures, develops and markets generics & pharmaceutical products | Health Technology |
TransMedics, Inc.
TransMedics, Inc. Medical SpecialtiesHealth Technology Manufactures and develops medical devices | Health Technology |
KasrAlAiny School of Medicine
KasrAlAiny School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransMedics Group, Inc.
TransMedics Group, Inc. Medical SpecialtiesHealth Technology Manufactures portable electromechanical medical devices for organ transplantation of end-stage organ failure patients | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen